Investor's Business Daily on MSN16 小时
Biohaven Just Hurdled An FDA Setback — And Its Moving Lines
Biohaven stock hurdled its 50-day and 200-day lines Tuesday after the FDA granted its SCA treatment a speedier review time.
The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for troriluzole for the treatment of adults with ...
Spinocerebellar Ataxia (SCA) is a rare, genetic, life-threatening neurodegenerative disease with no available treatment. Troriluzole demonstrated a 50-70% slowing of SCA disease progression ...
Melissa Beiner, M.D., SCA Clinical Development Lead at Biohaven, commented, Our NDA filing is the culmination of over 8 years of clinical research a ...
Understanding the neural circuits that drive anxiety may help researchers discover circuit-specific targets and therefore increase the precision of ...
For years, serotonin has been linked to anxiety, but new research flips the script—higher serotonin in the cerebellum might ...
Summary: New research reveals that serotonin in the cerebellum plays a crucial role in anxiety regulation. Scientists found ...
Restrictive eating behaviors, such as dieting and purging, involve the deliberate limitation of food intake to control body weight and shape. In contrast, emotional or uncontrolled eating behaviors, ...
17.Finally, I'll give one of my own. Any time I loan someone a pen, I keep the cap. Then, when they're done writing with it ...
In a study published in the journal Current Biology, Johns Hopkins researchers discovered that individual neurons in the ...
Neurodevelopmental disorders impact how the brain grows and functions. Conditions like autism and ...
Age-related brain atrophy, the gradual loss of neurons and shrinkage of brain tissue, is a natural part of aging, which can ...